Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Bispecific Molecules in Oncology: Analytical Tool

Reportlinker
Posted on: 04 Oct 18
Bispecific Molecules in Oncology: Analytical Tool

PR Newswire

NEW YORK, Oct. 4, 2018

NEW YORK, Oct. 4, 2018 /PRNewswire/ -- Bispecific molecules carry huge treatment potential within cancer immunotherapy. In broad strokes this therapeutic category can be divided into three classes: (I) cytotoxic effector cell redirectors/CTL response; (II) tumor-targeted immunomodulators; and (II) dual immunomodulators.

Read the full report: https://www.reportlinker.com/p05576157

Bispecific Molecules in Oncology: Analytical Tool is the most up to date and comprehensive commercial pipeline review and competitive assessment available on this hot and fast moving area in oncology. This unique product is truly the only one of its kind and is designed to give you a competitive edge in your bispecific drug intelligence.

Your Bispecific Molecules in Oncology: Analytical Tool is based on two decades of proven methodology in serving clients with interest in:
* Target Scouting
* Early & Late Stage Pipeline Analysis
* Biomarker/Companion Diagnostic Analysis
* Deal & Alliance Analysis
* Combination Therapy Analysis
* Clinical Trial Results Analysis
* Indication Selection & Expansion Analysis
* First-in-Class Analysis
* Drug Repositioning
* Pipeline Analysis by Targeted Pathways

Analytical Tools transform your computer's desktop into a high capacity workbench within your area of choice. Even before launching this tool you have already eliminated hundreds of hours of work needed to discover, process and piece together the thousands of sources that our team of oncology dedicated and highly experienced contents specialists have done on your behalf.

Your Bispecific Molecules in Oncology: Analytical Tool covers more than 149 companies plus partners who are today developing 390 bispecific drugs where of 327 are in active developmental in cancer across 153 different targets. Any data and/or analysis from the Analytical Tool is yours to keep and data/graphs/tables can be easily exported into Excel/PDF and various graphic formats for mixing with your own proprietary information.

Let our expertise work for you
While executing some of your daily tasks in our Analytical Tools, you will benefit from almost two decades of our experience in perfecting features and analysis, allowing you to easily create breakdowns, tables, graphs and exports for your reports, presentations and conference attendance via our easy to use point and click interface.

Support and inspiration at your finger-tips
You also have access to a great selection of How-to Training Videos showing best practice approaches to aspects such as competitive pipeline analysis right through to many real world case examples put forward by other users of our Analytical Tools.

A tool to grow with and keep you informed
Unlike a static report which just represents a particular snapshot in time, all of the Analytical Tools come with one year of free online access to twice-weekly updates in both contents and features, pipeline alerts and online support. You can choose to renew your access to these updates and support on a yearly basis or go over to our industry leading full service platform covering all oncology drug development, 1stOncology.

Your key to accessing the 1stOncology NewsDesk
As a special bonus, your Analytical Tool unlocks lifetime(*) access to the 1stOncology Newsdesk! This service, which is normally reserved for full 1stOncology users only, is a live stream of breaking news within the oncology industry. Updated every 5 minutes, you can tune in to specific channels such as Social Media, Clinical Trials, Intellectual Property, Financial data and Press Releases. This is a great tool to ensure your surveillance of your area of interest is complete.

Format & Free Updates
This is 12 months of access to an ever-green Analytical Tool that you access simply online. It is continuously updated with new information and analysis throughout your 12 month access period, ensuring that you stay up to date with this fast moving field. At the end of your access period, if you so wish, you can choose to renew.

System Requirements
- Browser Application (Supports: Internet Explorer, FireFox, Chrome and Safari))
- Internet access

(*) In this context, lifetime access refers to the full period of time that BioSeeker Group offers a Newsdesk product or similar news based service.

Read the full report: https://www.reportlinker.com/p05576157

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

View original content:http://www.prnewswire.com/news-releases/bispecific-molecules-in-oncology-analytical-tool-300724544.html

SOURCE Reportlinker

PR Newswire
www.prnewswire.com

Last updated on: 04/10/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.